Represented Dicerna in trade secret litigation regarding RNA interference technology. Settled before trial favorably for Dicerna.
Represented Dicerna in antitrust litigation with its competitor Alnylam in the RNA interference field. Settled favorably for Dicerna.
Representing Defendant Acrux in patent litigation over ANDA to make a generic version of Almirall’s topical acne product Aczone (dapsone). Pending.